Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitis

H Gregersen1, G Pedersen, N Svendsen

  • 1Department of Medicine B, Aalborg Hospital, Denmark. henrik.gregersen@dadlnet.dk

Insights

Individuals surviving serious pneumococcal infections, like pneumococcal pneumonia or meningitis, face an elevated risk of developing multiple myeloma. However, the overall absolute risk remains low.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Oncology

Background:

  • The association between serious pneumococcal infections and subsequent multiple myeloma risk is not well-established.
  • Pneumococcal infections, including bacteremia and meningitis, are significant public health concerns.

Purpose of the Study:

  • To investigate the incidence of multiple myeloma following community-acquired pneumococcal bacteremia and meningitis.
  • To quantify the risk of multiple myeloma in patients with severe pneumococcal infections.

Main Methods:

  • A cohort study was conducted using data from North Jutland, Denmark (1981-1996).
  • Identified 328 episodes of pneumococcal bacteremia and 77 of pneumococcal meningitis in individuals over 40.
  • Linked patient data to the Danish Cancer Registry to determine subsequent multiple myeloma diagnoses.

Main Results:

  • In the bacteremia cohort (1,218 patient-years), 7 multiple myeloma cases occurred versus 0.13 expected (SIR 53.5).
  • In the meningitis cohort (444 patient-years), 4 multiple myeloma cases occurred versus 0.05 expected (SIR 83.2).
  • Survivors of pneumococcal bacteremia or meningitis showed a significantly increased standardized incidence ratio for multiple myeloma.

Conclusions:

  • Community-acquired pneumococcal bacteremia and meningitis are associated with an increased risk of subsequent multiple myeloma.
  • While the relative risk is high, the absolute risk of developing multiple myeloma after these infections is low.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: